Evidence map›Paper›PMID 41890270›Full record

ArticleLeukemia research reports2026

Blastic plasmacytoid dendritic cell neoplasm: A single centre Indian experience.

Paramasivam Sabitha, Aastha Goel, Santhosh Kumar, Chethan R, Sanal Fernandes, Nitin Jain, Naveen Pemmaraju, Atul Sharma, Ranjit Kumar Sahoo

Abstract readCase Reports
In one paragraph

Article in Leukemia research reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paramasivam SabithaDepartment of Medical Oncology, Dr. B. R. Ambedkar IRCH, All India Institute of Medical Sciences, New Delhi, 110029, India.
Aastha GoelDepartment of Medical Oncology, Dr. B. R. Ambedkar IRCH, All India Institute of Medical Sciences, New Delhi, 110029, India.
Santhosh KumarDepartment of Medical Oncology, Dr. B. R. Ambedkar IRCH, All India Institute of Medical Sciences, New Delhi, 110029, India.
Chethan RDepartment of Medical Oncology, Dr. B. R. Ambedkar IRCH, All India Institute of Medical Sciences, New Delhi, 110029, India.
Sanal FernandesDepartment of Medical Oncology, Manipal hospitals, Mangaluru, 575001, India.
Nitin JainDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Naveen PemmarajuDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Atul SharmaMedical Oncology Department, Max Hospital, Saket, New Delhi, 110017, India.
Ranjit Kumar SahooDepartment of Medical Oncology, Dr. B. R. Ambedkar IRCH, All India Institute of Medical Sciences, New Delhi, 110029, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BPDCN is an uncommon haematological malignancy recognised as a distinct entity by the WHO in 2016. It typically presents with skin lesions and involves bone marrow, lymph nodes, and CNS, affecting all age groups. The disease poses significant diagnostic challenges, with limited data on optimal treatment strategies, further contributing to its dismal prognosis. Standard regimens include ALL-like or AML-like therapies, particularly in older adults. We outline our experiences managing three consecutive BPDCN patients, emphasising the unique challenges oncologists face when treating this malignancy. This underscores scarcity of effective therapies, limited expertise, and intricacies involved in managing such a complex disease.

Identifiers

PMID41890270
PMCPMC13014670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.